(VIANEWS) – The NASDAQ opens in less than two hours and Alnylam Pharmaceuticals‘s pre-market value is already 6.14% down.
The last session, NASDAQ Composite ended with Alnylam Pharmaceuticals (ALNY) rising 3.44% to $193.85. NASDAQ Composite rose 1.02% to $14,896.85, after five sequential sessions in a row of losses, on what was an all-around up trend trading session.
Today’s last reported volume for Alnylam Pharmaceuticals is 773143, 23.32% above its average volume of 626893.
Alnylam Pharmaceuticals’s last close was $193.85, 7.57% below its 52-week high of $209.73.
Alnylam Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth grew by 112.1%, now sitting on 687.53M for the twelve trailing months.
Alnylam Pharmaceuticals’s last day, last week, and last month’s current volatility was 3.44%, 1.54%, and 1.89%, respectively.
Alnylam Pharmaceuticals’s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 7.21% (day), 3.44% (last week), and 2.97% (last month), respectively.
More news about Alnylam Pharmaceuticals (ALNY).